MaxCyte (LON:MXCT)

MaxCyte (LON:MXCT)

Share Price
156.40 p
2.4 (1.56 %)
Market Cap
£85.94 m
Proactive Investors - Run By Investors For Investors


We are a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines.

We provide our patented, high-performance cell-engineering platform to biopharmaceutical partners engaged in drug discovery and development, biomanufacturing and cell therapy, including gene editing and immuno-oncology....

Market: AIM:MXCT
52-week High/Low: 250.040p / 150.000p
Sector: Pharma & Biotech
Market Cap: £85.94 m
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of MaxCyte

MaxCyte Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use